Answers are grounded in this paper and cite their sources.
Introduction Automated insulin delivery (AID) systems integrate continuous glucose monitoring (CGM) with algorithm-driven insulin dosing to enable closed-loop glycemic management for people with type 1 diabetes (T1D). Recent advances in wearable glucose sensing and insulin delivery technologies have enabled increasingly compact AID systems; however, deploying advanced AI-based dosing algorithms directly on resource-constrained wearable devices remains technically challenging. Some AID architectures also rely on external devices, such as smartphones or dedicated controllers, introducing additional communication dependencies into the closed-loop operation. Methods This study presents an on-device insulin dosing controller based on the soft actor–critic (SAC) algorithm for resource-constrained AID systems. The proposed approach processes CGM data and makes insulin dosing decisions locally, without relying on external computing devices. To enable embedded deployment, a compressed SAC architecture with a lightweight encoder was developed using quantization-aware training and knowledge distillation, together with an online adaptation mechanism for individualized control. The controller was implemented on a resource-constrained microcontroller and evaluated in a hardware-in-the-loop framework using virtual patients from a T1D simulator. Results The proposed controller achieved an average time-in-range of 83% while maintaining real-time on-device execution with millijoule-level energy consumption per control step. Discussion These hardware-in-the-loop and in-silico results demonstrate the technical feasibility of real-time reinforcement learning-based insulin dosing and personalization on a resource-constrained embedded platform, while clinical efficacy and safety require further validation.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: